INBIOGEN Co., Ltd. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was KRW 776.19 million compared to KRW 1,120.94 million a year ago. Net income was KRW 14,381.25 million compared to net loss of KRW 48,010.01 million a year ago.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
9,340 KRW | -2.30% | -.--% | -.--% |
1st Jan change | Capi. | |
---|---|---|
-.--% | 67.8M | |
+23.30% | 46B | |
+9.37% | 33.18B | |
+16.15% | 16.73B | |
-12.36% | 7.38B | |
+23.71% | 5.75B | |
+2.22% | 4.32B | |
-0.32% | 3.73B | |
-7.06% | 2.74B | |
+13.59% | 2.14B |
- Stock Market
- Equities
- A101140 Stock
- News INBIOGEN Co., Ltd.
- INBIOGEN Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023